Insider buying last 90 days
No open-market insider purchases were filed for CL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:15 pm ET.
Colgate-Palmolive trades at $87.47, down 0.3%, sitting between its 50-day average of $90.86 and 200-day average of $88.08. The GekkoIndex reads 69.5, placing the stock in the Accumulation zone. Gekko Fair Value stands at $90.43, putting the current price 3.3% below that level. Over the past month the stock is down 3.7%, though it remains up 6.4% over the past year.
This week's news centers on a possible divestment of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, in a deal reportedly worth over $1 billion, with Goldman Sachs said to be involved. Alongside this, the company declared its regular quarterly dividend of $0.53 per share, payable 13 November to shareholders of record 20 October, continuing a dividend history dating to 1895. Separate coverage discussed efforts to revive North America growth after a weak second quarter through premium innovation, advertising, and pricing. Bank of America disclosed a new stake of over 6 million shares, valued at approximately $567 million, during the second quarter.
Looking ahead, the next earnings date falls on 30 October, 40 days out and beyond a typical 20-trading-day holding window. Analyst coverage from 12 firms shows 8 buy and 4 hold ratings, with a consensus target of $98.95, implying 13.1% upside from current levels. Seasonality over the next 20 trading days has averaged -2.4% across 5 years, with no positive years in that stretch, a pattern worth noting alongside the pending brand-sale news.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Colgate-Palmolive scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $87.47 sits between the 50-day ($90.86) and 200-day ($88.08) averages, or the averages disagree.
See the chart69.5, Accumulation
Reading 69.5 is in the Accumulation zone.
See the GekkoIndex3.3% below
Price is within 5% of Gekko Fair Value (3.3% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 40 days
Next report Oct 30, 2026, 40 days away — outside a typical 20-trading-day hold.
See earnings−2.4% on average
From this point in the calendar, the next 20 trading days averaged −2.4% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Colgate-Palmolive closed at $87.47 on Sep 18, 2026, +6.4% over the past year, inside a 52-week range of $74.55 to $99.33.
Use the left and right arrow keys to read daily values.
Put CL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Colgate-Palmolive makes and sells everyday consumer products worldwide, with a lineup that spans toothpaste, toothbrushes and mouthwash alongside soaps, shampoos, deodorants and skin care items, plus household staples like dishwashing liquid, fabric conditioner and cleaners. It is widely recognized for its oral care line sold under its own name, one of many brands in its portfolio that also includes Palmolive, Softsoap, Irish Spring, Speed Stick, Sanex, Fabuloso and Ajax, among others.
The business runs through two divisions. One covers oral, personal and home care goods, reaching consumers through retail stores, online channels, wholesalers and distributors, and also supplies dental professionals with specialized products. The other division, Pet Nutrition, produces everyday and therapeutic pet food under the Hill's Science Diet and Hill's Prescription Diet names, sold through pet supply retailers, veterinary offices and online platforms.
The company was established in 1806 and is headquartered in New York, New York. Its shares are listed on the NYSE under the ticker CL.
Colgate-Palmolive’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.5, in the Accumulation zone, down 2.3 points over five sessions.
Down 2.3 points over five sessions, from the Buying zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +0.2% | −0.3% | ||
| Accumulation (current zone) | 238 | +0.1% | 0.0% | ||
| Neutral | 351 | +0.1% | +0.6% | ||
| Distribution | 42 | +0.2% | +1.6% | ||
| Selling | 3 | Too few readings yet | |||
Average CL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Colgate-Palmolive trades 3.3% below Gekko Fair Value of $90.43, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Colgate-Palmolive shares are worth, recalculated every trading day.
$90.43
Gekko Fair Value, Sep 19, 2026
3.3% below fair value · About fair value
No open-market insider purchases were filed for Colgate-Palmolive, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Colgate-Palmolive has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold CL.
Colgate-Palmolive reports on Oct 30, 2026, before the open (40 days away), and beat the EPS estimate in 7 of its last 8 reports.
Oct 30, 2026
Expected before the open, 40 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 1, 2026 | $0.80 est $0.95 | $5.32B est $5.22B | 0.0% |
| Jan 30, 2026 | $0.95 est $0.91 | $5.23B est $5.12B | +7.8% |
| Oct 31, 2025 | $0.91 est $0.89 | $5.13B est $5.13B | −2.0% |
| Aug 1, 2025 | $0.92 est $0.90 | $5.11B est $5.04B | −0.6% |
| Apr 25, 2025 | $0.91 est $0.86 | $4.91B est $4.87B | −1.9% |
| Jan 31, 2025 | $0.91 est $0.90 | $4.95B est $4.98B | −4.2% |
| Oct 25, 2024 | $0.91 est $0.89 | $5.03B est $5.01B | −4.0% |
| Jul 26, 2024 | $0.91 est $0.87 | $5.06B est $5.00B | +4.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Colgate-Palmolive is $98.95, +13.1% from the last close, from 12 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 12 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 15 | Bernstein | $99 | +13.2% |
| Sep 10 | Barclays | $87 | −0.5% |
| Sep 8 | RBC Capital | $104 | +18.9% |
| Aug 21 | Bank of America Securities | $102 | +16.6% |
| Aug 4 | Barclays | $87 | −0.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Colgate-Palmolive averaged −2.4% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.9% | 1 of 5 |
| Next 10 trading days | −3.3% | 0 of 5 |
| Next 15 trading days | −4.3% | 0 of 5 |
| Next 20 trading days | −2.4% | 0 of 5 |
| Next 30 trading days | −2.8% | 1 of 5 |
For scale, CL’s typical 20-trading-day move in either direction is about 3.4%.
Colgate-Palmolive’s market cap is $69.99B, with a P/E ratio of 34.3 and revenue of $21.05B over the last twelve months.
Coverage of Colgate-Palmolive this week reads positive: 11 positive, 10 neutral and 2 negative headlines.
Colgate-Palmolive’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 15.8% below |
| KVUEKenvue | Accumulation | 22.7% below |
| ELEstee Lauder Companies | Accumulation | 4.2% below |
| KMBKimberly-Clark | Buying | 19.5% below |
| CHDChurch & Dwight | Accumulation | 7.1% below |
| CLXClorox | Buying | 45.5% below |
A peer links to its own page where one exists.
Colgate-Palmolive’s market cap is $69.99B at the Sep 18, 2026 close of $87.47, with 797.2M shares outstanding. The shares trade on a P/E ratio of 34.3.
The consensus analyst 12-month price target for Colgate-Palmolive is $98.95, +13.1% from the last close. Of the 12 firms that rated the stock in the last 90 days, 8 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Colgate-Palmolive is about fair value: the Sep 18, 2026 close of $87.47 is 3.3% below Gekko Fair Value of $90.43. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Colgate-Palmolive is expected to report on Oct 30, 2026, before the market opens (40 days away). Analysts expect earnings of $0.92 per share on revenue of $5.34B. Colgate-Palmolive beat the earnings estimate in 7 of its last 8 reports, moving 3.1% on average across the report.
Colgate-Palmolive’s 52-week high is $99.33 and its 52-week low is $74.55; it closed at $87.47 on Sep 18, 2026, +6.4% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.